DAFTAR PUSTAKA

1. Indonesia DJPPr PLKK. Statistik Kasus HIV AIDS Indonesia. 2013. 5 July 2013.
2. Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, et al. HIV
infection-associated immune activation occurs by two distinct pathways that
differentially affect CD4 and CD8 T cells. Proceedings of the National Academy of
Sciences. 2008 December 16, 2008;105(50):19851-6.
3. Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral pada
orang Dewasa dan Remaja. Jakarta: Kementerian Kesehatan RI. 2012.
4. Aghnia JP, Eryati D, dan Efrida. Pola Infeksi Oportunistik yang Menyebabkan
Kematian pada Penyandang AIDS di RS Dr. M. Djamil Padang Tahun 2010-2012.
Jurnal Kesehatan Andalas. 2015; 4(1)
5. Segreti J. Pulmonary complication of HIV disease. In: Current medical diagnosis &
treatment 39thed. Conecticut: Prentice-Hall International; 2006. P.414-23.
6. Huang L, Cattamanchi A, Davis L, Boon S, Kovacs J, Meshnick S, et al. On behalf of
the International HIV-associated Opportunistic Pneumonias (IHOP) Study and the
Lung HIV Study. HIV-Associated Pneumocystic Pneumonia. Proc Am Thorac Soc
Vol 8. 2011, pp 294300.
7. Carmona EM and Limper AH. Update on the diagnosis and treatment of
Pneumocystic pneumonia. Ther Adv Respir Dis 2011 5: 41.
8. Kaur R, Wadhwa A, Bhalla P and Dhakad MS. Pneumocystic pneumonia in HIV
patients: a diagnostic challenge till date. Medical Mycology, 2015, 53, 587592.
9. Bennett NJ. Pneumocystic jiroveci Pneumonia Overview of Pneumocystic
jiroveciPneumonia.http://emedicine.medscape.com/article/225976overview. Updated:
Oct 19, 2016.
10. Napoli A.M, Maughan B, Murray R,Maloy K, and Milzman D. Use Of The
Relationship Between Absolute Lymphocyte Count And Cd4 Count To Improve
Earlier Consideration Of Pneumocystis Pneumonia In Hiv-Positive Emergency
Department Patients With Pneumonia. The Journal of Emergency Medicine, Vol. 44,
No. 1, pp. 2835, 2013.
11. Tasaka S. Pneumocystic Pneumonia in Human Immunodeficiency Virus infected
Adults and Adolescents: Current Concepts and Future Directions. Clinical Medicine
Insights: Circulatory, Respiratory and Pulmonary Medicine 2015:9(S1) 1928.
12. Morris A, Wei K, Afshar K and Huang L,. Epidemiology and Clinical Significance of
Pneumocystis Colonization. The Journal of Infectious Diseases 2008; 197:10 7
13. Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR,et al.
Pneumocystis colonisation is common among hospitalised HIV infected patients with
non-Pneumocystis pneumonia. Thorax 2008;63:329334.
14. Riebold D, Enoh DO, Kinge TN, Akam W, Bumah MK, Russow K. Pneumocystis
jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon.
Tropical Medicine and International Health. volume 19 no 6 pp 643655 june 2014
15. Sheikholeslami MF, Sadraei J, Farnia P, Forozandeh M, Kochak HE, Tabarsi P, et al.
Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease
(COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV+
immunocompromised patients. Iranian Journal of Microbiology. Vol.5,
No.4(December 2013) 411-417.
16. Morris A and Norris K. Colonization by Pneumocystis jirovecii and Its Role in
Disease. Clinical Microbiology Reviews p. 297317. 2012
17. Rozaliyani A, Antariksa B, Dianiati K.S, Wahyuningsih R. Pemeriksaan Real-time
PCR dalam Diagnosis Pneumonia Pneumocystic.J Respir Indo Vol. 31, No. 3, Juli
2011.
18. Gangneux FR, Belaz S, Revest M, Tattevin P, Jouneau S, Decaux O et al. Diagnosis
of Pneumocystic jirovecii Pneumonia in Immunocompromised Patients by Real-Time
PCR: a 4-Year Prospective Study. Journal of Clinical Microbiology 2014 Vol. 52
(9)p. 3370-76.
19. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E et al. Real-
time PCR assay-based strategy for differentiation between active Pneumocystic
jirovecii pneumonia and colonization in immunocompromised patients. Clin
Microbiol Infect 2011; 17: 15311537.
20. Caliendo AM, Hewitt PL, Allega JM, Keen A, Ruoff KL, Ferraro MJ, et al.
Performance of a PCR assay for detection of Pneumocystic carinii from respiratory
specimens. J Clin Microbiol. 2008 Apr;36(4):979-82.
21. Bennet N.J. HIV Disease-Overview. Available from http://emedicine. medscape.
com/article/211316 -overview. 2010
22. Maartens G, Celum C, and Lewin SR. HIV infection: epidemiology, pathogenesis,
treatment, and prevention. www.thelancet.com Published online June 5(14)60164-1,
2014.
23. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of Human
Immunodeficiency Virus infection. N Engl J Med. 2003; 328: 327-35.
24. Beck M.J. Abnormalities in Host Defense Associated with HIV Infection. Clin Chest
Med. 2013 June ; 34(2): 143153.
25. Alcam J. Advances in the immunopathogenesis of hiv infection. Enferm Infecc
Microbiol Clin 2004;22(8):486-96.
26. Rich EA. Activation-inactivation of HIV-1 in the lung. J Biomed Sci 2008;5:1-10.
27. Beck J. The immunocompromised host. Proc Am Thorax Soc 2005;2:423-7.
28. Hogan CM, and Hammer SM. Host determinants in HIV infection and disease part 1:
cellular and humoral immune response. Ann Intern Med 2001;134:761-76.
29. Twig HL. Impaired IgG production in the lungs of HIV-infected individuals. Cell
Immunol 2000;170:127-33.
30. Lu PX, Deng YY, Liu ST, Liu Y, Liu YX, Wang YX, et al. Correlation between
imaging features of Pneumocystic Jiroveci Pneumonitis (PCP), CD4+ T lymphocyte
count, and plasma HIV viral load: A study in 50 consecutive AIDS patients. Quant
Imaging Med Surg 2012;2(2):124-129.
31. Prickartz A, Lsebrink J, Khalfaoui S, Schildgen O,Schildgen V, Windisch W, et al.
Low Titer Pneumocystic jirovecii Infections: More than Just Colonization?. J. Fungi
2016, 2, 16; doi:10.3390/jof2020016.
32. Leibovitz E, Pollack H, Moore T, Papellas J, Gallo L, Krasinki K, et al. Comparison
of PCR and standard cytological staining for detection of Pneumocystis carinii from
respiratory specimens from patients with or at high risk for infection by human
immunodeficiency virus. J Clin Microbiol 2005;33:3004-7.
33. Turner D, Scwarz Y, and Yust I. Induced sputum for diagnosing Pneumocystis carinii
pneumonia inHIV patients: new data, new issues. Eur Respir J 2006;21:204-8.
34. Powledge TM. The polymerase chain reaction. Adv Physiol Educ 2004;28:44-50.
35. Kubista M, Andrade JM, Bengstsson M, Forootan A, Jonak J, Lind K, et al. The real-
time polymerase chain reaction. Mol Asp Med 2006;27:95-125.
36. Larsen HH, Masur H, Kovacs JA, Gill VJ, Silcott VA, Kogulan P, et al. Development
and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing
Pneumocystis pneumonia. J Clin Microbiol 2002;40:490-4.
37. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, et al. Comparison
between real-time PCR, conventional PCR and different staining techniques for
 diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage
specimens. J Med Microbiol 2004;53:603-7.
38. Louis M, Guitard J, Jodar M, Ancelle T, Magne D, Lascols O, et al. Impact of HIV
infection status on interpretation of quantitative PCR for detection of Pneumocystis
jirovecii. J Clin Microbiol 53:3870 3875. 2015.

Moir S, Chun ST,and Fauci AC. Pathogenic Mechanisms of HIV Disease. Annu. Rev. Pathol.
Mech. Dis. 2011.6:223-248. Downloaded from www.annualreviews.org.

Maartens G, Celum C, and Lewin SR. HIV infection: epidemiology, pathogenesis, treatment,
and prevention. www.thelancet.com Published online June 5, 2014
http://dx.doi.org/10.1016/S0140-6736(14)60164-1.

Naif HM. Pathogenesis of HIV infection. Licensee PAGE Press, Italy Infectious Disease
Reports 2013; 5:s1e6